鸦葱疱疹膏外用治疗带状疱疹的临床效果

doi:10.20047/j.issn1673-7210.2022.34.19

Abstract
Figure/Table
References (28)
Related Citation (15)

Download: PDF (692 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the clinical effect of herpes zoster (HZ) treated with topical Scorzonera Herpes Ointment. Methods Sixty patients with HZ who met the inclusion criteria and attended the No.988 Hospital of Logistic Support Forces of the Chinese People’s Liberation Army from September 2020 to October 2021 were selected and divided into treatment group and control group according to the random number table method, with 30 cases in each group. The treatment group was given topical Scorzonera Herpes Ointment and the control group was given topical Recombinant Human Interferon α2b Gel, while both were given oral acyclovir 0.4 g/time, 5 time/day. The efficacy was evaluated after 10 d of treatment, and were observed and compared the efficacy scores of comprehensive symptoms and signs and visual analogue scores (VAS) of pain in the two groups on days 3, 7, and 10 of HZ were observed and compared. The time of erythema reduction, cessation of blistering, crusting, and debridement were observed during the treatment in the two groups. The incidence of postherpetic neuralgia (PHN) was compared between the two groups at a month of treatment. Results The clinical efficacy of the treatment group was better than that of the control group, and the difference was statistically significant (P＜0.05). The differences were statistically significant when comparing the intergroup, time, and interaction effects of total HZ symptom and sign ratings between the two groups (P＜0.05). Among them, the total score of HZ symptoms and signs on day 3 was lower than that before treatment, the total score of HZ symptoms and signs on day 7 was lower than that before treatment and on day 3, while the total score of HZ symptoms and signs on day 10 was lower than that at other time points in both groups, and the differences were statistically significant (P＜0.05). Except before the treatment, the total score of HZ symptoms and signs in the treatment group at the same time point was lower than that in the control group, and the difference was statistically significant (P＜0.05). The erythema reduction time, blister stopping time, crusting time, and debridement time in the treatment group were shorter than those in the control group, and the differences were statistically significant (P＜0.05). There were a statistically significant differences between the two groups in terms of VAS scores between groups, time, and interaction (P＜0.05). In both groups, VAS scores on day 3 were lower than before treatment, VAS scores on day 7 were lower than before treatment and on day 3, and VAS scores on day 10 were lower than at other time points, with statistically significant differences (P＜0.05). Except before the treatment, the treatment group had lower VAS scores than the control group at the same time point, and the difference was statistically significant (P＜0.05). The incidence of PHN in the treatment group was lower than that in the control group, and the difference was statistically significant (P＜0.05). When comparing the incidence of adverse reactions between the two groups, and the difference was not statistically significant (P＞0.05). Conclusion The effect of topical treatment of HZ with opium herpes cream is remarkable, which can more effectively reduce skin lesions, shorten the course of disease and relieve pain. It is especially effective in the prevention of PHN, with no adverse reactions in clinical application, safe and effective, and worthy of clinical promotion.

Key words： Herpes zoster Scorzonera Herpes Zoster Ointment Visual analogue score Interferon

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SHEN Dexin* HUANGFU Jiaxin* QIN Zhen ZHENG Qinghu ZU Zhiyong ZHANG Guangyang LI Dengpan

Cite this article:

SHEN Dexin* HUANGFU Jiaxin* QIN Zhen ZHENG Qinghu ZU Zhiyong ZHANG Guangyang LI Dengpan. Clinical effect of herpes zoster treated with topical Scorzonera Herpes Ointment[J]. 中国医药导报, 2022, 19(34): 80-84.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2022.34.19 OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I34/80

[1] 朱谦，樊碧发，张达颖，等.周围神经病理性疼痛诊疗中国专家共识 [J].中国疼痛医学杂志，2020，26（5）：321-328.
[2] 盛宇俊，胡竹林，张安平.带状疱疹后遗神经痛的危险因素分析[J].皮肤病与性病，2021，43（1）：1-3.
[3] 中华医学会.临床诊疗指南：皮肤病与性病分册[M].北京：人民卫生出版社，2006：2-4．
[4] 王映辉，黄石玺，刘保延，等.火针赞刺法治疗带状疱疹的临床疗效评价研究[J].中国中医基础医学杂志，2009， 15（10）：774-777.
[5] 丁治云，李天举，龙亭，等.脐针联合药物治疗带状疱疹神经痛的临床效果[J].河南医学研究，2021，33：6261-6264.
[6] 国家中医药管理局.中医病症诊断疗效标准[M].南京：南京大学出版社，2012：190-191.
[7] 刘博，张晋松，卢凤艳，等.普瑞巴林治疗带状疱疹后遗神经痛疗效观察[J].皮肤病与性病，2022，44（1）：64-65.
[8] 肖延龄，张炳厚.张炳厚治疗带状疱疹后遗神经痛用药特色探微[J].中华中医药杂志，2020，35（3）：1254-1256.
[9] 《中华医学杂志社》皮肤科慢病能力提升项目，医师协会疼痛科医师分会国家远程医疗与互联网医学中心皮肤科专委会.带状疱疹相关性疼痛全程管理专家共识[J].中华皮肤科杂志，2021，54（10）：841-846.
[10] 熊梅，骆志成.带状疱疹流行病学研究进展[J].实用临床医药杂志，2022，26（7）：144-148.
[11] Scholz J，Finnerup NB，Attal N，et al. The IASP classification of chronic pain for ICD-11：chronic neuropathic pain [J]. Pain，2019，160（1）：53-59.
[12] 王成龙，宋涛.短时程脊髓电刺激与背根神经节双极脉冲射频治疗带状疱疹后神经痛的疗效比较[J].中国医科大学学报，2020，49（3）：280-283.
[13] 王钦，宋建民，李妍，等.脉冲射频胸背根神经节联合药物治疗老年重度带状疱疹后神经痛病人的镇痛效果及机制研究[J].实用老年医学，2022，36（3）：261-264.
[14] Tang Y，Ren C，Wang M，et al. Altered gray matter volume and functional connectivity in patients with herpes zoster and postherpetic neuralgia [J]. Brain Research，2021，1769（2）：147608.
[15] Lang P，Aspinall R. Vaccination for quality of Life：herpes zoster vaccine [J]. Aging Clin Exp Res，2021，33（4）：1113- 1122.
[16] 中国医师协会皮肤科医师分会带状疱疹专家共识工作组.带状疱疹中国专家共识[J].中华皮肤科杂志，2018， 51（6）：403-408.
[17] 黄高振，王亮，吴婧瑄，等.传统中药、针法与西药抗病毒治疗带状疱疹的疗效比较[J].湖北民族大学学报·医学版，2021，38（4）：16-20.
[18] 黄钟.阿昔洛韦联合甲泼尼龙治疗带状疱疹的临床疗效及不良反应分析[J].临床与实践，2021，25（31）：4504-4506.
[19] 张燕飞.干扰素治疗带状疱疹的用药策略[J].皮肤科学通报，2021，38（6）：543-547.
[20] Küpeli Akkol E，Bahadir Acikara O，Süntar I，et al. Ethnopharmacological evaluation of some Scorzonera species：in vivo anti-inflammatory and antinociceptive effects [J]. J Ethnopharmacol，2012，140（2）：261-270.
[21] Bahadlr Acikara ?魻，Ho?觢ek J，Babula P，et al. Turkish Scorzonera species extracts attenuate cytokine secretion via inhibition of NF-κB activation，showing anti-inflammatory effect in vitro [J]. Molecules，2016，21（1）：E43.
[22] Khobrakova VB，Nikolaev SM，Tolstikhina VV，et al. Immumomodulating properties of lignin glucoside from cultivated cells of Scorzonera hispanica L. [J]. J Pharm Chem，2003，37（7）：345-346.
[23] 杨辉，李秀荣.桃叶鸦葱抗抑郁作用的实验研究[J].中成药，2011，33（9）：1588-1589.
[24] 沈德新.鸦葱属的药用价值[J].中国医药导报，2020，17（18）：41-44.
[25] 周莹，张夫坤，孙跃秋，等.鸦葱提取液对水痘-带状疱疹病毒体外增殖作用的影响[J].中国生物制品学杂志，2022，35（3）：281-284.
[26] Süntar I，Acikara OB，Citoglu GS，et al. In vivo and in vitro evaluation of the therapeutic potential of some Turkish Scorzonera species as wound healing agent [J]. Curr Pharm Des，2012，18（10）：1421-1433.
[27] 许丽娟，韵磊，杨辉.桃叶鸦葱黄酮对脑缺血再灌注大鼠的保护作用[J].中国现代中药，2018，20（6）：691-710.
[28] Calis Z，Mogulkoc R，Baltaci AK. The Roles of Flavonols/ Flavonoids in Neurodegeneration and Neuroinflammation [J]. Mini Rev Med Chem，2020，20（15）：1475-1488.